Drug and Market Development Publishing, Pages: 123
... Market opportunities include: - Developing effective therapeutic vaccines through the selective manipulation of dendritic cell activity. ...
Arrowhead Publishers, Oct 2004, Pages: 233
... 4.4 The Promise of Vaccines for Colorectal Cancer Table 4.4 Therapeutic Vaccine Pipeline for Colorectal Cancer Graph 4.3 Therapeutic Vaccines for Colorectal ...
Datamonitor, Jan 2004, Pages: 146
... Examples include monoclonal antibodies, therapeutic vaccines, newer adjuvants and delivery systems. The niche sector of nosocomial infection vaccines...
Drug and Market Development Publishing, June 2004, Pages: 250
... and HIV.- Develop revolutionary vaccines against emerging threats, such as ebola, dengue, SARS, and rotavirus.- Produce therapeutic vaccines for unpreventable ...
Informa Healthcare, Jan 2006, Pages: 170
... one pathway. The ?immunotherapy? class comprises largely of therapeutic vaccines and monoclonal antibodies. Immunotherapy acts ...
Datamonitor, Oct 2007, Pages: 241
... Merck & Co and GSK currently dominate this market. Therapeutic vaccines offer hope for a cure, but are a long way from approval. ...
Bizacumen Inc., Nov 2009, Pages: 435
Human vaccines market comprises of prophylactic vaccines and therapeutic vaccines. A new entrant in the vaccines market is the pediatric combination vaccine. ...
AMID Co., March 2006, Pages: 200
... Main Adult Vaccine Products Output of Adult Vaccine and Forecast Cost of Adult Vaccines Adult Vaccines in Development Therapeutic Vaccines Overview Output of ...
Informa Healthcare, Jan 2007, Pages: 175
... of a tumour 24 1.3.3 The treatment of cancer 24 1.4 Immunisation 25 1.5 Types of vaccine 26 1.5.1 Prophylactic vaccines 26 1.5.2 Therapeutic vaccines 27 1.5.3 ...
General Biologic, Dec 2007, Pages: 72
... V Vaccine R&D in China Novel prophylactic vaccines - HIV vaccines - H5N1 bird flu - Hepatitis E vaccine - SARS vaccine Novel therapeutic vaccines - Hepatitis B ...
Datamonitor, Aug 2002 ... by sales of erythropoietins and insulins, while future growth will reflect the increasing significance of monoclonal antibodies and therapeutic vaccines. ...
Global Industry Analysts, Inc., May 2008, Pages: 865
... The major product segments analyzed are Prophylactic Vaccines (Pediatric Prophylactic Vaccines, & Adult Prophylactic Vaccines), and Therapeutic Vaccines. ...
Datamonitor, May 2009, Pages: 131
... ISCOM-based technologies could be valuable for therapeutic vaccines, while liposomes and micro-/nanoparticles will not play a major role for vaccine delivery ...
